Multi Target Bioactivity Models in Pipeline Pilot
Upcoming SlideShare
Loading in...5
×
 

Multi Target Bioactivity Models in Pipeline Pilot

on

  • 90 views

 

Statistics

Views

Total Views
90
Slideshare-icon Views on SlideShare
89
Embed Views
1

Actions

Likes
0
Downloads
2
Comments
0

1 Embed 1

http://www.slideee.com 1

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Multi Target Bioactivity Models in Pipeline Pilot Multi Target Bioactivity Models in Pipeline Pilot Presentation Transcript

    • Multi-target bioactivity models in Pipeline Pilot Using ligand and target information Gerard JP van Westen Pipeline Pilot UGM (17-1-2013)
    • Cool things to do with PP • Multi-target bioactivity models ▫ The why… ▫ The how… ▫ The results… (time permitting)
    • The why.. a target is never alone… • Drug targets often have similar paralogs ▫ Selectivity is required • Viral targets often mutate leading to resistance ▫ Broad activity is required • Non-similar proteins have been shown to share ligands ▫ E.g. acetylcholine and serotonin
    • Molecular Similarity Efavirenz, EFV (NNRTI) Emtricitabine, FTC (NRTI) Lamivudine, 3TC (NRTI) 2
    • Molecular Similarity Emtricitabine, FTC (NRTI) 1.0 0.9 0.3 0.9 1.0 0.4 0.3 0.4 1.0 2 2
    • Sequence Similarity Emtricitabine, FTC (NRTI) 1.0 0.9 0.3 0.9 1.0 0.4 0.3 0.4 1.0 Phenylalanine Tyrosine Arginine
    • Sequence Similarity Emtricitabine, FTC (NRTI) 1.0 0.9 0.3 0.9 1.0 0.4 0.3 0.4 1.0 FYI IYF WTF FYI IYF WTF
    • The how… what is PCM ? • Proteochemometric modeling combines both a ligand descriptor and target descriptor GJP van Westen, JK Wegner et al. MedChemComm (2011),16-30, 10.1039/C0MD00165A
    • What is PCM ? • Proteochemometric modeling combines both a ligand descriptor and target descriptor GJP van Westen, JK Wegner et al. MedChemComm (2011),16-30, 10.1039/C0MD00165A Bio-Informatics
    • What is PCM ? • Proteochemometric modeling combines both a ligand descriptor and target descriptor Bio-Informatics GJP van Westen, JK Wegner et al. MedChemComm (2011),16-30, 10.1039/C0MD00165A
    • PCM using Pipeline Pilot • For this work we use mostly: ▫ Chemistry (circular fingerprints) ▫ Data modeling ▫ R statistics components (machine learning) • Lacking was a protein descriptor type component… • (In addition I missed some validation components…) ▫ Matthews Correlation Coefficient ▫ R2 to a line through the origin (R2 zero)
    • Target descriptors • Simple way to derive protein descriptors 1. Select the binding pocket 2. Align the relevant residues 3. Convert to physicochemical properties
    • Target descriptors
    • • PP component can create different protein descriptors 1. ProtFP Feature: J. Med. Chem. 2012, 55, 7010-7020 ; BMC Bioinformatics 2012, Submitted 2. ProtFP PCA: BMC Bioinformatics 2012, Submitted 3. Z-Scales : J. Med. Chem. 1998, 41, 2481-2491 4. VHSE : Biopolymers 2005, 80, 775-786 5. ST-Scales : Amino Acids 2010, 38, 805-816 6. T-Scales : J. Mol. Struct. 2007, 830, 106-115 7. MS-WHIM J. Chem. Inf. Comp. Sci. 1999 39, 525-533 8. FASGAI : Eur. J. Med. Chem. 2009, 44, 1144-1154 9. Blosum62 : J. Comp. Biol. 2009, 16, 5, 703-723 Target Descriptors Revised version of paper to be submitted
    • Visualized in PP
    • Visualized in PP 4 1 2 3 5 Feature Based
    • Visualized in PP 4 1 2 3 5 Feature Based 4 5 3 2 1 Physicochemical Properties
    • • The example is using Z-scales by Sandberg et al. • Uses a PCA to derive 5 principal components that describe amino acid similarity ▫ Based on side chain physicochemical properties • We use first 3 ▫ 1 – Lipophilicity ▫ 2 – Size ▫ 3 – Charge / Polarity M Sandberg, L Eriksson J Med Chem (1998) 41: 2481 - 2491 Target Descriptors
    • • Dataset Provide by Tibotec and Virco • Antivirogram® assay • Patient data • Reverse Transcriptase and Protease sequences • Fold Change in –logIC50 Target Amino acids Binding Site Drug Class Drugs Mutant Sequences Data points Reverse Transcriptase 400* Orthosteric NRTI 8 10,501 72,727 Reverse Transcriptase 400* Allosteric NNRTI 4 10,723 35,249 Protease 99 Orthosteric PI 9 27,081 180,162 Example Data set GJP van Westen, A Hendriks et al. PLoS Comp Biol (2013) Accepted / In press
    • Example Data set
    • Methods
    • Results
    • • What is important to our models? • What residue position? • What mutation is present at that position? • How much is contributed to resistance? • Bioactivity spectra can be obtained from these models Feature Importance
    • Feature Importance
    • • Currently we have applied the technique using PP to: • Adenosine receptors (human + rat) • HIV inhibitors (preclinical lead optimization) • HIV inhibitors (clinical drugs) • OATP1 inhibitors • Aminergic GPCRs • … Data sets
    • Acknowledgements • Ad IJzerman • Andreas Bender • Alwin Hendriks • Herman van Vlijmen • Joerg Wegner • Anik Peeters • John Overington • George Papadatos
    • Multi-target bioactivity models in Pipeline Pilot Using ligand and target information Gerard JP van Westen www.gjpvanwesten.nl Pipeline Pilot UGM (17-1-2013)
    • Model validation (classification) • PP lacked a component to calculate correlation coefficients between two properties in the data stream in (binary) classification.
    • Model validation (regression) • PP lacked a component to calculate correlation coefficients between two properties in the data stream in regression. (R2 zero, etc) A. Tropsha; Predictive Quantitative Structure-Activity Relationships Modeling; in Handbook of Chemoinformatics Algorithms (2010) J. Faulon and A. Bender; Editors.
    • Ligand Descriptors • Scitegic Circular Fingerprints ▫ Circular, substructure based fingerprints ▫ Maximal radius of 3 bonds from central atom ▫ Each substructure is converted to a molecular feature Carbon Oxygen Substructure
    • Fingerprints Carbon Oxygen Substructure
    • Fingerprints CC C Carbon Oxygen Substructure
    • Fingerprints C AA A CC C N OC C Carbon Oxygen Substructure
    • Fingerprints C AA A CC C C N O Carbon Oxygen Substructure